JDR JDR Most Read Articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruwanpura, S.M.P.M.
Right arrow Articles by Ishikawa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruwanpura, S.M.P.M.
Right arrow Articles by Ishikawa, I.

Prostaglandin E2 Regulates Interleukin-1ß-induced Matrix Metalloproteinase-3 Production in Human Gingival Fibroblasts

S.M.P.M. Ruwanpura1,2,*, K. Noguchi1,2, and I. Ishikawa1,2

1 Periodontology, Department of Hard Tissue Engineering, Graduate School, and 2 Centre of Excellence Program for Frontier Research on Molecular Destruction of Tooth and Bone, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8549, Japan;



View larger version (18K):

[in a new window]
 
Figure 1. Effect of indomethacin on MMP-3 (A,B) and PGE2 (C) production in IL-1ß-stimulated HGF derived from healthy gingiva. These cells were stimulated with vehicle or 2 ng/mL IL-1ß in the presence or absence of 1 µM of indomethacin for 72 hrs. After incubation, MMP-3 (A) and PGE2 levels (C) and caseinolytic activities (B) in the culture media were evaluated by enzyme-linked immunosorbent assay and casein zymography, as described in MATERIALS & METHODS. Values are mean + SD (n = 4). Data are representative of 3 separate experiments. *Significantly different from control (p < 0.0001). **Significantly different from IL-1ß alone (p < 0.001). #Significantly different from control (p < 0.0001). ##Significantly different from IL-1ß alone (p < 0.001).

 



View larger version (52K):

[in a new window]
 
Figure 2. Effects of PGE2, various EP agonists, or cAMP-elevating agents on MMP-3 levels and activities in IL-1ß-stimulated HGF derived from healthy gingiva. Cells were stimulated with vehicle or 2 ng/mL IL-1ß in the presence of 1 µM indomethacin, with or without various doses of PGE2, 17 phenyl-{omega}-trinor PGE2, butaprost, and ONO-AE-1329 for caseinolytic activity assay (A,B,C,D), or with or without various doses of PGE2, 1 µM of 17 phenyl-{omega}-trinor PGE2, 1 µM of butaprost, 1 µM of ONO-AE1-329, 100 µM of dibutyryl cAMP (dbcAMP), and 10 µM of forskolin (FS) for MMP-3 protein level assay (E,F,G,H), for 72 hrs. After incubation, caseinolytic activities and MMP-3 protein levels in the culture media were assayed by casein zymography and enzyme-linked immunosorbent assay, respectively, as described in MATERIALS & METHODS. Values are mean ± SD (n = 4). Data are representative of 3 separate experiments. *Significantly different from indomethacin+1L-1ß (p < 0.05). **Significantly different from indomethacin+1L-1ß (p < 0.0001). ***Significantly different from indomethacin+1L-1ß (p < 0.001). #Significantly different from indomethacin+1L-1ß (p < 0.05). $Significantly different from indomethacin+1L-1ß (p < 0.05). $$Significantly different from indomethacin+1L-1ß (p < 0.005). @Significantly different from indomethacin+1L-1ß (p < 0.0001).

 


View larger version (25K):

[in a new window]
 
Figure 3. Effect of indomethacin on MMP-3 (A,B) and PGE2 (C) production in IL-1ß-stimulated HGF derived from periodontally affected tissue. Cells were stimulated with vehicle or 2 ng/mL IL-1ß in the presence or absence of 1 µM of indomethacin for 72 hrs. After incubation, MMP-3 (A) and PGE2 (C) levels and caseinolytic activities (B) in the culture media were evaluated by enzyme-linked immunosorbent assay and casein zymography, as described in MATERIALS & METHODS. Values are mean ± SD (n = 4). Data are representative of 3 separate experiments. *Significantly different from control (p < 0.0001). **Significantly different from IL-1ß alone (p < 0.001). #Significantly different from control (p < 0.0001). ##Significantly different from IL-1ß alone (p < 0.001).

 


View larger version (23K):

[in a new window]
 
Figure 4. Effects of PGE2, 17 phenyl-{omega}-trinor PGE2, butaprost, and ONO-AE1-329 on production of MMP-3 in IL-1ß-stimulated HGF derived from periodontally affected gingiva. Cells were stimulated with vehicle or 2 ng/mL IL-1ß in the presence of 1 µM indomethacin, with or without various doses of PGE2, 17 phenyl-{omega}-trinor PGE2, butaprost, and ONO-AE1-329 for caseinolytic activity assay (A,B,C,D), or with or without 1 µM of PGE2, 17 phenyl-{omega}-trinor PGE2, butaprost, and ONO-AE1-329 for MMP-3 protein level assay (E), for 72 hrs. After incubation, caseinolytic activities and MMP-3 protein levels in the culture media were assayed by casein zymography and enzyme-linked immunosorbent assay, respectively, as described in MATERIALS & METHODS. Values are mean ± SD (n = 4). Data are representative of 3 separate experiments. *Significantly different from indomethacin+IL-1ß (p < 0.0001).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2004 Institutional Access Guidelines